Citadel Advisors’s Safeguard Scientifics, Inc. SFE Stock Holding History

Citadel Advisors’s Portfolio SFE Stock Details SFE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-17,900	Closed	-$159K	–	15071
2021 Q3	$159K	Sell	17,900 -3,900	-18%	-$31.2K	﹤0.01%	12302
2021 Q2	$169K	Buy	21,800 +3,400	+18%	+$23.2K	﹤0.01%	12370
2021 Q1	$125K	Buy	+18,400	New	+$134K	﹤0.01%	12252
2020 Q3	–	Sell	-26,700	Closed	-$187K	–	10936
2020 Q2	$187K	Hold	26,700	–	–	﹤0.01%	8580
2020 Q1	$148K	Buy	+26,700	New	+$239K	﹤0.01%	8313
2019 Q4	–	Sell	-11,100	Closed	-$126K	–	9935
2019 Q3	$126K	Buy	+11,100	New	+$132K	﹤0.01%	8380
2014 Q3	–	Sell	-900	Closed	-$19K	–	8487
2014 Q2	$19K	Buy	900 +100	+13%	+$2.01K	﹤0.01%	7319
2014 Q1	$18K	Buy	+800	New	+$15.9K	﹤0.01%	7336

Other funds holding SFE

CCM

Contrarian Capital Management Greenwich, Connecticut $357M AUM 18.27% 1-Year Est. Return

YCM

Yakira Capital Management Westport, Connecticut $342M AUM 26.97% 1-Year Est. Return

First Manhattan New York $36.1B AUM 11.5% 1-Year Est. Return

Almitas Capital Santa Monica, California $443M AUM 42.36% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

CM Management Gulf Breeze, Florida $120M AUM 37.12% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

MAP

Madison Avenue Partners New York $2.3B AUM 115.82% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Citadel Advisors's SFE Position: Q2 2023 in Review

Citadel Advisors sold out of Safeguard Scientifics, Inc. (SFE) in Q2 2023, closing a stake of 12,460 shares — an estimated $21.4K sold.

Citadel Advisors first reported a position in SFE in Q2 2013 and held it in 20 quarters. The position peaked at $896K in Q3 2021. 45 funds tracked by Wall St. Rank hold SFE as of Q2 2023.

Citadel Advisors reported no remaining Safeguard Scientifics, Inc. position as of Q2 2023 after selling out during the quarter.
Citadel Advisors sold 12,460 Safeguard Scientifics, Inc. shares in Q2 2023, an estimated $21.4K.
Citadel Advisors first reported a position in Safeguard Scientifics, Inc. in Q2 2013 and held it in 20 quarters.
Citadel Advisors's Safeguard Scientifics, Inc. position peaked at $896K in Q3 2021.
45 funds tracked by Wall St. Rank held Safeguard Scientifics, Inc. as of Q2 2023.

Based on Citadel Advisors's 13F filing for Q2 2023, filed 14 Aug 2023.